Inter Pharma PCL (BKK: IP)

Market Cap	2.19B
Revenue (ttm)	1.81B
Net Income (ttm)	10.52M
Shares Out	605.34M
EPS (ttm)	0.02
PE Ratio	208.36
Forward PE	n/a
Dividend	0.02 (0.60%)
Ex-Dividend Date	n/a

Volume	400,149
Open	3.460
Previous Close	3.500
Day's Range	3.460 - 3.800
52-Week Range	3.120 - 9.050
Beta	0.57
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Inter Pharma PCL

Inter Pharma Public Company Limited manufactures, imports, and distributes dietary supplement products for humans and animals in Thailand. It operates through three: Human Healthcare, Animal Healthcare, and Hospital segments. The company offers human, anti-aging, and human products, such as medical supplies, nutrition therapy, cosmetics, supplementary foods, probiotic and prebiotic products, health food products, general food products, medical equipment and medicines, etc.; functional foods and drinks; and pharmaceutical products; It also provi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Country: Thailand
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: IP

Financial Performance

In 2023, Inter Pharma PCL's revenue was 1.80 billion, an increase of 17.23% compared to the previous year's 1.53 billion. Earnings were 50.79 million, a decrease of -57.28%.